Stocks · Health care · Pharmaceutical Preparations

Theravance Biopharma, Inc.

TBPH Clue Score61
United States Fiscal year ends December CIK 0001583107 Results filed 10 Aug 2026

What the insiders did Net selling

By person

14 insiders · 20 transactions
0.3×

Rick E Winningham holds only 0.3 times base salary in stock. $398.60K of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Rick E Winningham last reported holding, valued at $17.03, the price Ordinary Shares was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Eli Samaha
10% owner
—
$5.79M (3)
−$5.79M
9,174,453
$156.28M
−3.5%
Eran Broshy
Director
—
$1.66M (5) scheduled
−$1.66M
44,703
$761.48K
−63.5%
Rhonda Farnum
SVP, Comm & Medical Affairs
—
$1.46M (12) scheduled
−$1.46M
0
$0.00
−100.0%
Jeremy T Grant
Director
—
—
—
32,954
$561.35K
+47.7%
Rick E Winningham
Chief Executive Officer
—
—
—
23,400
$398.60K
−98.8%
Dean J Mitchell
Director
—
—
—
0
$0.00
−100.0%
Susannah Gray
Director
—
—
—
0
$0.00
−100.0%
Donal O'Connor
Director
—
—
—
0
$0.00
−100.0%
Aziz Sawaf
SVP & Chief Financial Officer
—
—
—
0
$0.00
−100.0%
Aine Miller
SVP, Dev & Head of Ire Office
—
—
—
0
$0.00
−100.0%
Brett A. Grimaud
SVP, Gen Counsel and Secretary
—
—
—
0
$0.00
−100.0%
Alsup Laurie Smaldone
Director
—
—
—
0
$0.00
−100.0%
Deepika Pakianathan
Director
—
—
—
0
$0.00
−100.0%
Weiss Asset Management LP entity
Former 10% Owner
—
—
—
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.